This was actually a bit better than i thought it would be. Not great but it also reads that this quarterly if COVID doesn't cause anymore massive issues should be the end of the bad results.
IC money now coming in so they should have rougly US$ 56mil in the bank with drawdown of the financing from Upwell. And the end of the year is usually their strongest.
Overheads down 22% which is good.
Y 2020 guidance reaffirmed. Good.
“As experienced previously, we expect the fourth quarter to be our strongest for the year. We see customers rapidly adapting to the new global working environment amidst the pandemic. We also expect to continue to book new orders in China, the USA, the Middle East, and other areas around the world." sounds good.
IC behind us. Now it is all about SPS sales.
First pilot order for Aspiral TM Micro in China which is encouraging.
This was actually a bit better than i thought it would be. Not...
Add to My Watchlist
What is My Watchlist?
